Tratamientos eficaces para prevenir la enfermedad grave en pacientes COVID-19 (ABRIL 2021)
Channel: Andres Delgado
Date: 2021-04-09

Donaciones: 
https://www.buymeacoffee.com/andresdelgado​

Mi sitio web: 
https://doctor.delgado.ec​

FACEBOOK: https://www.facebook.com/andresdelgadoec​
TWITTER: https://www.twitter.com/andresdelgadoec​
YOUTUBE: https://www.youtube.com/andresdelgadoec

Fuentes:

Regeneron Pharmaceuticals Inc. Regeneron Reports Positive Interim Data with REGEN-COVTM Antibody Cocktail used as Passive Vaccine to Prevent COVID-19 [Internet]. 2021 [accessed 2021 Apr 7]. Available from: https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-positive-interim-data-regen-covtm-antibody

Tardif J-C, Bouabdallaoui N, L’allier PL, Gaudet D, Shah B, Pillinger MH, et al. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. medRxiv. 2021;2021.01.26.21250494. 

Lopes MI, Bonjorno LP, Giannini MC, Amaral NB, Menezes PI, Dib SM, et al. Beneficial effects of colchicine for moderate to severe COVID-19: A randomised, double-blinded, placebo-controlled clinical trial. RMD Open. 2021;7(1). 

Cadegiani FA, McCoy J, Gustavo Wambier C, Vaño-Galván S, Shapiro J, Tosti A, et al. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial. Cureus. 2021;13(2). 

Adsuara Cadegiani F, McCoy J, Gustavo Wambier C, Kovacevic M, Shapiro J, Sinclair R, et al. Proxalutamide (GT0918) Reduces the Rate of Hospitalization and Death in COVID-19 Male Patients: A Randomized Double-Blinded Placebo-Controlled Trial. 

Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW, et al. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021;384(11):1015–27. 

Libster R, Pérez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, et al. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 2021;384(7):610–8.